The US drugmaker Eli Lilly has bowed to demands from Donald Trump by raising the prices of its weight-loss jab for UK customers.

Danish drugmaker Novo Nordisk introduced its weight-loss drug Wegovy in South Africa on Thursday, marking its debut in Africa and stepping up competition with Eli Lilly's Mounjaro which launched in the country eight months ago.

Although many have boasted about weight loss success since using Mounjaro, last year it was revealed that Scots nurse Susan McGowan, 58, died after taking low-dose injections of Mounjaro over a ...

Rosie O’Donnell posted a photo of her dramatic weight loss on Instagram on Tuesday, Aug. 12. The 63-year-old comedian went on a shopping trip and discovered that she has gone down a clothing size.

While Mounjaro is a dual GIP/GLP-1 agonist, Ozempic and Wegovy are both GLP-1 agonists, known chemically as semaglutide, that are currently approved to treat Type 2 diabetes and weight loss ...

"This is a real concern for all patients who have been benefiting from this medicine. There will be panic and hysteria out there. The price changes will lead many to abruptly stopping their drug and this could be risky.

A WOMAN has revealed how she shed weight even after stopping Mounjaro. Arlene Taggart, from the UK, took to social media to share her weight loss transformation which left people stunned.

The survey of 2,000 weight loss patients found that a doubling in price would see 80% coming off Mounjaro, with 51% switching to Wegovy and 29% – around 326,000 people – stopping their weight loss medication altogether.